The Ohio State University Medical Center

Heparin-Induced Thrombocytopenia

In order to view this program you must log in. If you do not have an account, please register for one.

Viewing the webcast requires use of the free RealPlayer. RealPlayer

If you are having problems viewing the program, please check out our technical support section.

Credits1.00
Release Date2/15/2008
Termination Date2/15/2011
Cost $25.00 to view the program and complete a post test for CME credit.   To purchase this program please log in.
DescriptionAccording to the New England Journal of Medicine, Heparin-induced thrombocytopenia is a life-threatening disorder that follows exposure to unfractionated or low-molecular-weight heparin. Thrombotic complications develop in approximately 20 to 50 percent of patients.
Accreditation StatementThe Ohio State University Medical Center, Center for Continuing Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The Ohio State University Medical Center designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
AuthorEric Kraut, MD and Spero Cataland, MD
ObjectivesUpon completion of this educational activity, the viewer should be able to: 1.) Describe the pathophysiology and clinical cause of HIT. 2.) Evaluate appropriate management of HIT.
AudienceThis course is designed for physicians.
Estimated Time to Complete1 Hour